Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Long-Term Investments (2019 - 2026)

Phibro Animal Health has reported Long-Term Investments over the past 7 years, most recently at $367000.0 for Q4 2025.

  • For Q4 2025, Long-Term Investments fell 93.31% year-over-year to $367000.0; the TTM value through Dec 2025 reached $367000.0, down 93.31%, while the annual FY2025 figure was $89000.0, 98.28% down from the prior year.
  • Long-Term Investments for Q4 2025 was $367000.0 at Phibro Animal Health, up from $42000.0 in the prior quarter.
  • Over five years, Long-Term Investments peaked at $13.4 million in Q4 2022 and troughed at $42000.0 in Q3 2025.
  • A 5-year average of $5.5 million and a median of $5.0 million in 2021 define the central range for Long-Term Investments.
  • Biggest five-year swings in Long-Term Investments: skyrocketed 381.31% in 2022 and later crashed 99.34% in 2025.
  • Year by year, Long-Term Investments stood at $4.7 million in 2021, then surged by 183.38% to $13.4 million in 2022, then crashed by 67.22% to $4.4 million in 2023, then grew by 25.24% to $5.5 million in 2024, then tumbled by 93.31% to $367000.0 in 2025.
  • Business Quant data shows Long-Term Investments for PAHC at $367000.0 in Q4 2025, $42000.0 in Q3 2025, and $89000.0 in Q2 2025.